About this Research Topic
Within the umbrella term of uncommon or rare forms of diabetes, many forms exist such as: monogenic diabetes, mitochondrial diabetes, cystic fibrosis related diabetes, drug-induced diabetes, and diabetes associated with rare syndromes. In these forms, early diagnosis is essential to reduce the appearance of long-term complications. But, these forms being so rare, people can often be misdiagnosed. In these cases genetics could play an important role. It is very important to recognize these uncommon types of diabetes, the treatment being directed towards the underlying etiology.
Unlike type 1 and 2 diabetes, which are better known by both pediatricians and adult diabetes specialists, the rare or uncommon forms can be more difficult to diagnose and monitor. Also, we must not forget the fact that even these rare or uncommon forms can be accompanied by micro- and macrovascular complications, and periodic screening is required. This Research Topic aims to highlight the current state of diagnosis and possibilities of treatment, as well as future perspectives.
We would like the articles to be published in this collection to be a real help for those involved in the diagnosis and management of these uncommon or rare forms, as well as among family doctors. We encourage clinicians and researchers worldwide to contribute their insights on the latest discoveries pertaining to the pathogenesis, advancements in diagnostic and treatment, and other relevant factors of uncommon or rare forms of diabetes.
Topics include uncommon forms of diabetes, including but not limited to:
• drug-induced diabetes,
• diabetes secondary to infections (rubella, cytomeglaovirus),
• immune-mediated diabetes,
• genetic syndromes associated with diabetes (Down, Turner, Klinefelter, etc.),
• diabetes from endocrinopathies (Hyperthyroidism, Acromegaly, Cushing),
• genetic defects in insulin secretion and of beta-cell function.
Article types welcome include: original research, reviews, case reports.
Topic Editor Valeria Grancini has received grants for speeches from Vertex Europe; other Topic Editors declare no conflict of interest
Unlike type 1 and 2 diabetes, which are better known by both pediatricians and adult diabetes specialists, the rare or uncommon forms can be more difficult to diagnose and monitor. Also, we must not forget the fact that even these rare or uncommon forms can be accompanied by micro- and macrovascular complications, and periodic screening is required. This Research Topic aims to highlight the current state of diagnosis and possibilities of treatment, as well as future perspectives.
We would like the articles to be published in this collection to be a real help for those involved in the diagnosis and management of these uncommon or rare forms, as well as among family doctors. We encourage clinicians and researchers worldwide to contribute their insights on the latest discoveries pertaining to the pathogenesis, advancements in diagnostic and treatment, and other relevant factors of uncommon or rare forms of diabetes.
Topics include uncommon forms of diabetes, including but not limited to:
• drug-induced diabetes,
• diabetes secondary to infections (rubella, cytomeglaovirus),
• immune-mediated diabetes,
• genetic syndromes associated with diabetes (Down, Turner, Klinefelter, etc.),
• diabetes from endocrinopathies (Hyperthyroidism, Acromegaly, Cushing),
• genetic defects in insulin secretion and of beta-cell function.
Article types welcome include: original research, reviews, case reports.
Topic Editor Valeria Grancini has received grants for speeches from Vertex Europe; other Topic Editors declare no conflict of interest
Keywords: diabetes, uncommon forms, rare forms, genetic, endocrinopathies, children, adults
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
